Navigation Links
UC Irvine study points to new approach to influenza's antiviral resistance
Date:7/13/2011

Researchers from the University of California, Irvine, with assistance from the San Diego Supercomputer Center at UC San Diego, have found a new approach to the creation of customized therapies for virulent flu strains that resist current antiviral drugs.

The findings, published online this week in Nature Communications, could aid development of new drugs that exploit so-called flu protein 'pockets.'

Using powerful computer simulations on SDSC's new Trestles system, launched earlier this year under a $2.8 million National Science Foundation (NSF) award, UCI's Rommie Amaro and Robin Bush together with SDSC's Ross Walkercreated a method to predict how pocket structures on the surface of influenza proteins promoting viral replication can be identified as these proteins evolve, allowing for possible pharmaceutical exploitation.

"Our results can influence the development of new drugs taking advantage of this unique feature," said Amaro, an assistant professor of pharmaceutical sciences and computer science at UCI. Prior to joining UCI in 2009, Amaro was a postdoctoral fellow in chemistry at UC San Diego.

The search for effective flu drugs has always been hampered by the influenza virus itself, which mutates from strain to strain, making it difficult to target with a specific pharmaceutical approach. The most common clinical flu treatments are broad-based and only partially effective. They work by interrupting the action of an enzyme in the virus called neuraminidase, which plays a critical role in viral replication.

In 2006, scientists discovered that avian influenza neuraminidase (N1) exhibited a distinctive, pocket-shaped feature in the area pinpointed by clinically used drugs. They named it the 150-cavity.

Amaro and Bush, associate professor of ecology and evolutionary biology, conducted research using resources at the San Diego Supercomputer Center, as well as the National Institute for Computational S
'/>"/>

Contact: Jan Zverina
jzverina@sdsc.edu
858-534-5111
University of California - San Diego
Source:Eurekalert

Page: 1 2

Related medicine news :

1. UC Irvine Medical Center honors 9 for nursing excellence
2. UC Irvine Medical Center recognized for heart failure program
3. UC Irvine Medical Center is recognized for its commitment to organ donation
4. VOICE study will continue as it considers what action to take after results of 2 trials
5. Pivotal study in Africa finds that HIV medications prevent HIV infection
6. UAB researchers present a study on the psychological adaptation of adopted children
7. Bed Sores Afflict More Blacks in Nursing Homes Than Whites: Study
8. More U.S. Men Die From Cancer Than Women: Study
9. Older Women at Greater Risk for Common STD, Study Suggests
10. Bladder Cancer Patients Not Getting Recommended Care: Study
11. Fast Food Is King of the Neighborhood, Study Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... of the top public health concerns in the United ... as obese as of 2012. As health problems such ... to Twitter to discuss the problem. , A new ... at the Brown School at Washington University in St. ... tweets to track Twitter conversations about the issue of ...
(Date:7/10/2014)... EAST LANSING, Mich. For those students looking to ... answer may not be spending more time in a ... New Michigan State University research shows that students who ... on MSU,s campus during their freshman and sophomore years ... The research also indicated that students with memberships stayed ...
(Date:7/10/2014)... at the University of Huddersfield could help to improve ... food products such as butter, mayonnaise, yoghurt and ... an international profile for her work. , Katerina gained ... the University and now she has embarked on research ... Vassilis Kontogiorgos, she is investigating the potential of carbohydrates ...
(Date:7/10/2014)... A neuroscientist at Rutgers University-Newark says the human brain ... a finding that could provide a better understanding ... conditions that afflict an estimated 13.6 million Americans. , ... , Michael Cole, an assistant professor at the Center ... brain architecture of a person at rest is basically ...
(Date:7/10/2014)... the Bellvitge Biomedical Research Institute (IDIBELL) and the Catalan ... patients a new therapeutic combination to combat resistant sarcomas. ... treatment could stabilize the growth of these tumors have ... of Cancer ., Sarcomas , Sarcomas are a ... several subtypes. It can affect from children to older ...
Breaking Medicine News(10 mins):Health News:Study looks at how Twitter can be used to address specific health issues 2Health News:Want a higher GPA in college? Join a gym 2Health News:World interest in research work on the benefits of the Okra plant 2Health News:Working to loosen the grip of severe mental illness 2Health News:New therapeutic combination to slow resistant sarcomas 2
... panic. The following summarizes a new list of suggestions ... non-partisan National Center for Policy Analysis. Authored by NCPA ... full article is not sponsored by any commercial entity, ... Link to full article: http://www.ncpa.org/pdfs/Seven_Ways_Job_3-16-09-FINAL-A.pdf Here ...
... ... Newark, DE (PRWEB) March 17, 2009 ... ) have demonstrated that single embryos cultured under proper conditions ... successfully in women under age 35. In national results ...
... 17 eCardio Diagnostics ( www.ecardio.com ) announced ... Medicine initiative to provide a tailored offering to ... time an arrhythmia monitoring company has addressed the ... medical centers. "At eCardio, we work closely ...
... Leading HIFU device in Mexico for Minimally Invasive ... draws attention from elite urologistsCHARLOTTE, N.C., March 16 ... the Mexican and international entities of USHIFU, a ... of high intensity focused ultrasound (HIFU) technologies, will ...
... Boston, Mass. - Many households harbor a threat to ... tables and tables with glass panels. A review by ... publisher of Consumer Reports, finds that glass-table injuries aren,t ... could have been avoided had tempered glass been used. ...
... Less Than $1 MillionGross Margin Increases to 57.1%Programs ... & 2010First Quarter Sales Off to Strong StartMONROVIA, ... STAA ), a leading developer, manufacturer ... reported financial results for the fourth quarter and ...
Cached Medicine News:Health News:7 Ways to Keep Health Coverage If You Lose Your Job 2Health News:Most IVF Patients Under 35 Should Have Single Embryo Transfer, According to Latest SART Data 2Health News:Most IVF Patients Under 35 Should Have Single Embryo Transfer, According to Latest SART Data 3Health News:eCardio Diagnostics Launches Academic Medicine Initiative 2Health News:High Intensity Focused Ultrasound Physician Training Seminar in Mexico City 2Health News:Glass tables: An overlooked safety threat 2Health News:STAAR Surgical Reports 14% Fourth Quarter Revenue Growth 2Health News:STAAR Surgical Reports 14% Fourth Quarter Revenue Growth 3Health News:STAAR Surgical Reports 14% Fourth Quarter Revenue Growth 4Health News:STAAR Surgical Reports 14% Fourth Quarter Revenue Growth 5Health News:STAAR Surgical Reports 14% Fourth Quarter Revenue Growth 6Health News:STAAR Surgical Reports 14% Fourth Quarter Revenue Growth 7Health News:STAAR Surgical Reports 14% Fourth Quarter Revenue Growth 8Health News:STAAR Surgical Reports 14% Fourth Quarter Revenue Growth 9Health News:STAAR Surgical Reports 14% Fourth Quarter Revenue Growth 10Health News:STAAR Surgical Reports 14% Fourth Quarter Revenue Growth 11Health News:STAAR Surgical Reports 14% Fourth Quarter Revenue Growth 12Health News:STAAR Surgical Reports 14% Fourth Quarter Revenue Growth 13Health News:STAAR Surgical Reports 14% Fourth Quarter Revenue Growth 14Health News:STAAR Surgical Reports 14% Fourth Quarter Revenue Growth 15Health News:STAAR Surgical Reports 14% Fourth Quarter Revenue Growth 16Health News:STAAR Surgical Reports 14% Fourth Quarter Revenue Growth 17Health News:STAAR Surgical Reports 14% Fourth Quarter Revenue Growth 18Health News:STAAR Surgical Reports 14% Fourth Quarter Revenue Growth 19Health News:STAAR Surgical Reports 14% Fourth Quarter Revenue Growth 20Health News:STAAR Surgical Reports 14% Fourth Quarter Revenue Growth 21Health News:STAAR Surgical Reports 14% Fourth Quarter Revenue Growth 22Health News:STAAR Surgical Reports 14% Fourth Quarter Revenue Growth 23Health News:STAAR Surgical Reports 14% Fourth Quarter Revenue Growth 24Health News:STAAR Surgical Reports 14% Fourth Quarter Revenue Growth 25
(Date:1/15/2014)... Jan. 15, 2014 Reportlinker.com announces that ... in its catalogue: ... and Market Analysis to 2022 ... Dermatitis - India Drug Forecast and Market ...
(Date:1/15/2014)... NEW YORK , Jan. 15, 2014 ... research report is available in its catalogue: ... Technologies for Advanced Drug Delivery Systems -- ... http://www.reportlinker.com/p01940411/Global-Markets-and-Technologies-for-Advanced-Drug-Delivery-Systems----Focus-on-End-Users.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology STUDY OBJECTIVES ...
(Date:1/15/2014)... CAMBRIDGE, Mass. , Jan. 15, 2014  Zafgen, ... the unmet needs of severely obese patients, today ... of beloranib, a selective inhibitor of methionine aminopeptidase ... a severe form of genetic obesity.  These results ...
Breaking Medicine Technology:PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 16Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 18Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4
... Today FRC Action joined 19 pro-life groups in a letter sent to Food ... consideration for FDA approval that can cause abortions but is misleadingly labeled as an "emergency ... Tom McClusky ... the following comments: , , , ...
... INDIANAPOLIS , July 28 Eli Lilly and Company (NYSE: ... the Federal Circuit has upheld a prior ruling by the U.S. District Court ... invalid. , , , ... ruling by the U.S. Court of Appeals regarding Gemzar,s method-of-use patent. We continue ...
Cached Medicine Technology:FRC Action and Pro-Life Coalition Urge the FDA to Reject New Abortion-Causing Drug 2U.S. Court of Appeals Rules on Validity of Lilly's Gemzar Method-of-Use Patent 2U.S. Court of Appeals Rules on Validity of Lilly's Gemzar Method-of-Use Patent 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: